Call us

Online event
The pharmaceutical sector before, during and after the COVID-19 crisis

Monday, 18 May 2020


Andrzej Rys
Director for Health systems, medical products and innovation, DG Sante, European Commission
Bart van Zijll Langhout
Vice President, Strategic Alliances Janssen EMEA, Johnson & Johnson
Nathalie Moll
Director General, European Federation of Pharmaceutical Industries and Associations


Claire Dhéret
Head of the Social Europe and Well-being Programme, European Policy Centre

The COVID-19 pandemic is having a devastating impact on every aspect of our lives and putting a strain on every sector of the society and the economy. The health sector is one of the hardest hit sectors and is in the frontline in the fight against the virus, from hospitals, health systems and workers, to research laboratories and pharmaceutical companies. How has the pharmaceutical industry been affected by the COVID-19 crisis and what is its role in addressing this public health emergency? What measures have been put in place to combat the virus and are they sufficient? With shortages of medical supplies, can Europe build up a strategic autonomy in the pharmaceutical sector? And will the ongoing crisis facilitate the emergence of a ‘Europe of Health’? This online policy dialogue will shed light on these and other questions while reflecting on the industrial vision post-coronavirus and the role of the pharmaceutical industry. The discussion will be moderated by Claire Dhéret, Head of the EPC Social Europe and Well-being Programme.

The latest from the EPC, right in your inbox
Sign up for our email newsletter
14-16 rue du Trône, 1000 Brussels, Belgium | Tel.: +32 (0)2 231 03 40
EU Transparency Register No. 
89632641000 47
Privacy PolicyUse of Cookies | Contact us | © 2019, European Policy Centre

edit afsluiten